Prospective open-label, multicenter phase IV study of liver-function-adjusted tacrolimus therapy after liver transplantation.

Trial Profile

Prospective open-label, multicenter phase IV study of liver-function-adjusted tacrolimus therapy after liver transplantation.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 30 Jun 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Liver transplant rejection
  • Focus Pharmacokinetics
  • Acronyms GRAFTT
  • Most Recent Events

    • 07 Jun 2014 Trial status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 03 Jul 2013 New source identified and integrated (German Clinical Trials Register record: DRKS00003551).
    • 19 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top